CANSINO BIOLOGICS IN

6185

End-of-day quote - 01/15
234.2HKD	+1.83%

Prev.	230.0000
Open	235.4000
High	246.6000
Low	231.0000
Volume	1 950 178

4d ago	Malaysia imposes 2-week lockdown as virus spread strains hospitals
01/03	Explainer-Where are we in the COVID-19 vaccine race?
12/31	What we know about China-made vaccines
12/30	China gives its first COVID-19 vaccine approval to Sinopharm

	Short Term	Mid-Term	Long Term
Trend	Bullish	Neutral	Bullish
Resistance	249	271	271
Spread/Res.	-6,0%	-14%	-14%
Spread/Supp.	25%	64%	64%
Support	187	143	143

Sales 2020	94,1 M 14,5 M 14,5 M
Net income 2020	-6,87 M -1,06 M -1,06 M
Net cash 2020	2 901 M 448 M 448 M
P/E ratio 2020	-7 789x
Yield 2020	-

Capitalization	68 339 M 10 547 M 10 546 M
EV / Sales 2020	695x
EV / Sales 2021	17,7x
Nbr of Employees	429
Free-Float	37,1%

CanSino Biologics Inc is a clinical-stage vaccine company in China. The Company's products include Ad5-EBOV vaccine used for Ebola virus, MCV2 and MCV4 vaccines for meningococcus, PBPV vaccine used for pneumococcal and the recombinant novel coronavirus vaccine. Its products are mainly used in...

>> Read more

Sector :

Biopharmaceuticals

Calendar :

2021-03-29 Earnings Release

Trading Rating :

Investor Rating :

Mean consensus	BUY
Number of Analysts	6
Average target price	171,22 CNY
Last Close Price	195,73 CNY
Spread / Highest target	11,1%
Spread / Average Target	-12,5%
Spread / Lowest Target	-76,4%